Found 8 matching trials
Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents
NACoronary artery stents have improved the safety and efficacy of percutaneou...
Location
Kantonsspital Aarau
Trial of MiStent Compared to Xience in Japan
NATo compare the MT005 (MiStent) with the XIENCE with respect to target lesio...
Location
Iwaki Municipal Iwaki Kyoritsu Hospital
Personalized Vs. Standard Duration of Dual Antiplatelet Therapy and New-generation Polymer-Free vs- Biodegradable-Polymer DES
PHASE4New-generation metallic drug-eluting stents represent the standard of care ...
Location
Casa di Cura Villa Dei Fiori
ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS
PHASE4The purpose of this study is to evaluate the safety of reducing dual antipl...
Location
Kyoto University Graduate School of Medicine
Patient Centered Machine Learning Model for Bleeding and Ischemic Risk
N/ADual antiplatelet therapy (DAPT) is indicated in all patients undergoing co...
Location
Icahn School of Medicine at Mount Sinai
The Dual Antiplatelet Therapy Study (DAPT Study)
PHASE4The DAPT Study is a double blind randomized controlled trial intended to de...
Bioresorbable Polymer-Coated EES in Patients at High Bleeding Risk Undergoing PCI Followed by 1-Month DAPT
PHASE4Objective: To evaluate the safety of bioresorbable polymer-coated everolimu...
Location
Humanitas Research Hospital
Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention
PHASE4The duration of dual antiplatelet treatment (i.e. asprin and clopidogrel) a...
Location
Azienda Ospedaliera Universitaria di Ferrara